CAPTRUST FINANCIAL ADVISORS - Astellas Pharma Inc ownership

Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 9 filers reported holding Astellas Pharma Inc in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of Astellas Pharma Inc
ValueSharesWeighting
Q2 2022$79,000
+23.4%
5,085
+24.4%
0.00%
Q1 2022$64,000
+3.2%
4,089
+7.9%
0.00%
Q4 2021$62,000
+10.7%
3,790
+11.8%
0.00%
Q3 2021$56,000
-5.1%
3,3890.0%0.00%
-100.0%
Q2 2021$59,000
+15.7%
3,389
+2.5%
0.00%0.0%
Q1 2021$51,000
+13.3%
3,306
+14.4%
0.00%0.0%
Q4 2020$45,000
+150.0%
2,890
+136.9%
0.00%
Q3 2020$18,000
+350.0%
1,220
+369.2%
0.00%
Q2 2020$4,0002600.00%
Other shareholders
Astellas Pharma Inc shareholders Q1 2022
NameSharesValueWeighting ↓
RENAISSANCE GROUP LLC 483,681$7,616,0000.34%
TODD ASSET MANAGEMENT LLC 202,400$3,153,0000.07%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 202,400$3,153,0000.03%
SILVERCREST ASSET MANAGEMENT GROUP LLC 112,575$1,772,0000.01%
Private Capital Group, LLC 1,084$17,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 43$1,0000.00%
IFP Advisors, Inc 511$8,0000.00%
MEEDER ASSET MANAGEMENT INC 23$00.00%
CAPTRUST FINANCIAL ADVISORS 4,089$64,0000.00%
View complete list of Astellas Pharma Inc shareholders